The NCI Division of Cancer Prevention funds new research in cancer prevention, detection, screening, interception, and symptom management. We also fund programs to train people for careers in research. Explore current open funding opportunities here and streamline your search by using keyword or type of funding.
Information about the funding opportunity announcements that align with the efforts of the Cancer MoonshotSM can be found here: https://www.cancer.gov/research/key-initiatives/moonshot-cancer-initiative/funding .
Notice of Funding Opportunities
Title
Announcement Number
Activity Code
Clinical Trials Status
Expiration Date
Sort descending
Program Official
Pancreatic Cancer Detection Consortium: Research Units
PAR-21-334 (U01 Clinical Trial Optional)
U01
Clinical Trial Optional
06/12/2024
Matthew Young, Ph.D.
Notice of Special Interest (NOSI): Administrative Supplement to Support the NCI Cancer Prevention-Interception Targeted Agent Discovery Program (CAP-IT) Research
NOT-CA-24-047
06/14/2024
Vignesh Gunasekharan, Ph.D.
Notice of Special Interest (NOSI): HEAL Initiative: Clinical Translation of Diagnostic and Therapeutic Devices via Blueprint MedTech
NOT-NS-23-002
06/21/2024
Understanding Chronic Conditions Understudied Among Women
RFA-OD-23-013 (R21 Clinical Trial Optional)
R21
Clinical Trial Optional
06/21/2024
Goli Samimi, Ph.D., M.P.H.
Understanding Chronic Conditions Understudied Among Women
RFA-OD-23-014 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
06/21/2024
Goli Samimi, Ph.D., M.P.H.
Notice of Special Interest: Administrative Supplements to Support Collection of Spanish Normative Data and Determination of Test-Retest Reliability Estimates of Neuropsychological Tests for NCI Clinical Trials
NOT-CA-24-040
06/22/2024
Cecilia Lee, Dr.P.H., R.N.
Consortium for Palliative Care Research Across the Lifespan
RFA-AG-25-002 (U54 Clinical Trial Optional)
U54
Clinical Trial Optional
07/03/2024
Brennan Streck, Ph.D., R.N., M.P.H.
Cancer Immunoprevention Network (CIP-Net) Research Projects
RFA-CA-23-029 (UG3/UH3 Clinical Trials Not Allowed)
UH3, UG3
07/04/2024
Altaf Mohammed, Ph.D.
Mechanisms that Impact Cancer Risk after Bariatric Surgery
PAR-21-331 (R01 Clinical Trial Optional)
R01
Clinical Trial Optional
09/08/2024
Edward Sauter, M.D., Ph.D.
Basic Research in Cancer Health Disparities
PAR-21-323 (R21 Clinical Trial Not Allowed)
R21
Clinical Trial Not Allowed
09/08/2024
Asad Umar, D.V.M., Ph.D.